Dilated Cardiomyopathy (DCM)
Dilated Cardiomyopathy (DCM) is a severe heart muscle disease characterized by the thinning and stretching of the heart’s chambers, leading to impaired blood pumping. DCM poses a significant health challenge, affecting a substantial global population, with estimates suggesting a prevalence as high as 1 in 250 individuals. This disorder, often striking younger adults, brings about substantial morbidity and mortality, primarily due to heart failure and sudden cardiac death. Despite its impact, key gaps in scientific knowledge hamper effective patient management.
DCM-NEXT Project:
Welcome to DCM-NEXT, an innovative project dedicated to improving how we understand and treat Dilated Cardiomyopathy (DCM). Our mission is twofold:
Genetic Insight: We’re diving deep into the genetic roots of DCM to better understand how it works in the body. By doing this, we aim to make genetic testing more precise, helping us predict when someone might get sick and how severe it might become.
Better Treatments: We’re on a mission to find new ways to treat DCM by understanding what causes it on a molecular level. This means moving beyond just treating the symptoms and getting to the core of the problem, potentially changing the way we approach DCM treatment altogether.